Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Scholar Rock Holding Corporation - Common Stock (NQ:SRRK)

53.37 +1.04 (+1.99%)
Streaming Delayed Price Updated: 11:06 AM EDT, Jun 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 492,120
Open 52.33
Bid (Size) 53.31 (100)
Ask (Size) 53.39 (200)
Prev. Close 52.33
Today's Range 52.27 - 53.67
52wk Range 27.07 - 53.71
Shares Outstanding 94,873,407
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire

Performance

YTD
+24.7%
+24.7%
1 Month
+3.6%
+3.6%
3 Month
+17.5%
+17.5%
6 Month
+16.4%
+16.4%
1 Year
+59.7%
+59.7%

More News

Read More
News headline image
Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference
From Scholar Rock, Inc.
Via Business Wire
Scholar Rock (SRRK) Q1 Loss Narrows In Line Awaits PDUFA Decision ↗
Via Chartmill
Scholar Rock Holding Corp (NASDAQ:SRRK) Posts Q4 Loss, Awaits Apitegromab Approval in 2026 ↗
Via Chartmill
News headline image
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock, Inc.
Via Business Wire
News headline image
What to Know About This Fund’s $50 Million Exit From Ascendis Pharma ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO ↗
Via The Motley Fool
Topics Initial Public Offering
News headline image
Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Scholar Rock Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Scholar Rock (SRRK) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock to Present at the BofA Securities 2026 Health Care Conference
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
News headline image
CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
From Scholar Rock
Via Business Wire
News headline image
Scholar Rock (SRRK) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million ↗
Via The Motley Fool
News headline image
Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26% ↗
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Scholar Rock Holding Corporation - Common Stock publicly traded?
Yes, Scholar Rock Holding Corporation - Common Stock is publicly traded.
What exchange does Scholar Rock Holding Corporation - Common Stock trade on?
Scholar Rock Holding Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Scholar Rock Holding Corporation - Common Stock?
The ticker symbol for Scholar Rock Holding Corporation - Common Stock is SRRK on the Nasdaq Stock Market
What is the current price of Scholar Rock Holding Corporation - Common Stock?
The current price of Scholar Rock Holding Corporation - Common Stock is 53.37
When was Scholar Rock Holding Corporation - Common Stock last traded?
The last trade of Scholar Rock Holding Corporation - Common Stock was at 06/25/26 11:06 AM ET
What is the market capitalization of Scholar Rock Holding Corporation - Common Stock?
The market capitalization of Scholar Rock Holding Corporation - Common Stock is 5.06B
How many shares of Scholar Rock Holding Corporation - Common Stock are outstanding?
Scholar Rock Holding Corporation - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.